<h2 class="mt-4 text-lg font-medium text-color-lightgreytext" data-astro-cid-fjd3bvuv>
Summary from the AllSides News Team
</h2> <div class="mt-2 text-md editor-content" data-astro-cid-fjd3bvuv><p>A ruling is expected soon in a case that could limit access to a key&nbsp;abortion pill, reigniting national discourse on the issue.&nbsp;</p>

<p><strong>The Details:</strong> A coalition of conservative and pro-life groups <a href="https://adflegal.org/sites/default/files/2022-11/Alliance-for-Hippocratic-Medicine-v-FDA-2022-11-18-Complaint.pdf" target="_blank" rel="noopener noreferrer">sued</a> the FDA in November, alleging that the drug regulator “exceeded its regulatory authority” and neglected its own standards when it approved mifepristone, an abortion pill, in 2000. If U.S. District Court Judge Matthew Kacsmaryk sides with the group, the FDA’s approval could be vacated, and mifepristone could be removed from the market.</p>

<p><strong>For Context: </strong>Today, the <a href="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-about-mifepristone-medical-termination-pregnancy-through-ten-weeks-gestation" target="_blank" rel="noopener noreferrer">FDA</a> says the drug is “safe when used as indicated and directed,” adding that periodic reviews “have not identified any new safety concerns.” However, some pro-life critics have noted a risk of <a href="https://lozierinstitute.org/fact-sheet-risks-and-complications-of-chemical-abortion/#_edn3" target="_blank" rel="noopener noreferrer">bleeding</a> after using abortion pills. Pills account&nbsp;for over half of the abortions in the U.S.; according to the Guttmacher Institute, an abortion rights group, <a href="https://www.guttmacher.org/2023/02/10-us-states-would-be-hit-especially-hard-nationwide-ban-medication-abortion-using" target="_blank" rel="noopener noreferrer">98%</a> of those abortions use a combination of mifepristone and another&nbsp;drug, misoprostol, which can still end a pregnancy on its own.&nbsp;</p>

<p><strong>Related News:</strong> <a href="/news/2023-03-03-0652/healthcare-walgreens-won-t-distribute-abortion-pills-some-states-where-they">Walgreens said Thursday</a>&nbsp;that it was not distributing mifepristone and that it did not intend to distribute it — in stores or by mail — in 20 states where attorneys general had said it would be illegal.&nbsp;</p>

<p><strong>How the Media Covered It: </strong>Generally, perspectives in right-rated outlets were supportive of the lawsuit, and perspectives in left-rated outlets were opposed. Some health writers in center-rated outlets warned against politicizing the issue.&nbsp;</p>
</div> <h2 class="mb-2 leading-6 text-lg text-gray-500 font-medium mt-4 p-0">
Featured Coverage of this Story
</h2> <div class="flex gap-5 my-2 mb-8 md:flex-row flex-col"> <div class="flex-1 left"><div class="mb-2 font-bold border-solid global-bias-label text-color-left border-b-[3px] text-s border-color-left">From the Left</div><a id="News-Item--what-to-know-about-the-texas-abortion-pill-ruling-its-impact-on-access" href="https://www.washingtonpost.com/politics/2023/03/01/abortion-pill-ruling-texas/" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">What to know about the Texas abortion pill ruling, its impact on access</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">Washington Post</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-left.png" alt="AllSides Media Bias Rating: Lean Left" title="AllSides Media Bias Rating: Lean Left" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/imrs_61.jpeg" alt="What to know about the Texas abortion pill ruling, its impact on access" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">Paul Ratje for The Washington Post</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">Analysis</div><div class="[&>p]:my-2 text-sm editor-content"><p>A federal judge in Texas is likely to rule soon in a case that could halt distribution of a key&nbsp;abortion&nbsp;drug — a decision that would have sweeping implications for abortion access across the country, including in Democratic-led states where abortion rights are protected.</p><p>The lawsuit, filed by several antiabortion groups and doctors against the U.S. Food and Drug Administration, aims to undo the decades-old government approval of mifepristone, one of the two drugs used in a medication abortion.</p><p>If the judge in the case,&nbsp;Matthew Kacsmaryk&nbsp;of the Northern District of Texas,...</div><a id="Open-On--washington-post" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.washingtonpost.com/politics/2023/03/01/abortion-pill-ruling-texas/" target="_blank" rel="noopener">
Open on Washington Post<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a><div class="flex-1 whitespace-nowrap text-gray-500 text-xs leading-4 flex mt-2"><div class="hover:cursor-help" data-tippy-content="<p><span style=&#34;white-space: nowrap;&#34;>Some content from this outlet may be</span><br><span style=&#34;white-space: nowrap;&#34;>limited or behind a paywall.</span></p>"><i class="fa-regular fa-sack-dollar mr-1"></i><span class="whitespace-nowrap">Possible Paywall</span></div></div></div></div><script type="46f48578e074caacf1f16cbf-module" src="/_astro/story-related-news.astro_astro_type_script_index_0_lang.DjPUAy8u.js"></script><div class="flex-1 center"><div class="mb-2 font-bold border-solid global-bias-label text-color-center border-b-[3px] text-s border-color-center">From the Center</div><a id="News-Item--as-a-ban-on-one-abortion-pill-looms-providers-look-to-the-other-as-a-fallback-but-that-isn-t-ideal" href="https://www.statnews.com/2023/02/10/abortion-pill-texas-mifepristone-misoprostol/" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">As a ban on one abortion pill looms, providers look to the other as a fallback. But that isn’t ideal</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">STAT</p></div><img src="https://img.allsides.com/sites/default/files/bias-center.png" alt="AllSides Media Bias Rating: Center" title="AllSides Media Bias Rating: Center" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/GettyImages-1241524154-1600x900.jpg" alt="As a ban on one abortion pill looms, providers look to the other as a fallback. But that isn’t ideal" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">ROBYN BECK/AFP VIA GETTY IMAGES</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">Analysis</div><div class="[&>p]:my-2 text-sm editor-content"><p>In stories about medication abortions, we often give mifepristone a starring role. We&nbsp;call&nbsp;the dashing biochemist who developed it “the father of the abortion pill,”&nbsp;noting&nbsp;his youth spent in the French Resistance and his glamorous, Vanity-Fair-worthy flings. We see it in the&nbsp;headlines&nbsp;pretty frequently, dragging its trusty sidekick misoprostol in tow. Later this month, a Trump-appointed judge in Texas may well ban it from the sanctioned market by&nbsp;ordering&nbsp;the Food and Drug Administration to overturn its approval.</p><p>So it might seem surprising that American abortion providers are responding to that threatened prohibition by&nbsp;preparing&nbsp;to forego...</div><a id="Open-On--stat" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.statnews.com/2023/02/10/abortion-pill-texas-mifepristone-misoprostol/" target="_blank" rel="noopener">
Open on STAT<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a></div></div><div class="flex-1 right"><div class="mb-2 font-bold border-solid global-bias-label text-color-right border-b-[3px] text-s border-color-right">From the Right</div><a id="News-Item--pro-life-plaintiffs-confident-law-is-on-their-side-as-abortion-pill-ruling-looms" href="https://www.nationalreview.com/news/pro-life-plaintiffs-confident-law-is-on-their-side-as-abortion-pill-ruling-looms/" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">Pro-Life Plaintiffs Confident Law Is on Their Side as Abortion-Pill Ruling Looms</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">National Review (News)</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-right.png" alt="AllSides Media Bias Rating: Lean Right" title="AllSides Media Bias Rating: Lean Right" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/misoprostol.jpg" alt="Pro-Life Plaintiffs Confident Law Is on Their Side as Abortion-Pill Ruling Looms" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">Evelyn Hockstein/Reuters</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>Supporters and opponents of chemical-abortion pills are bracing for a ruling in the coming days or weeks that could radically alter how abortions are performed in the United States, stemming from a lawsuit that claims that the Food and Drug Administration never had the authority to approve the use of the pills when it did so nearly a quarter century ago.</p><p>The FDA also failed to properly study the safety of the two-pill regimen of mifepristone and misoprostol, and for almost two decades it stonewalled the doctors who were attempting...</div><a id="Open-On--national-review-news-" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.nationalreview.com/news/pro-life-plaintiffs-confident-law-is-on-their-side-as-abortion-pill-ruling-looms/" target="_blank" rel="noopener">
Open on National Review (News)<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a><div class="flex-1 whitespace-nowrap text-gray-500 text-xs leading-4 flex mt-2"><div class="hover:cursor-help" data-tippy-content="<p><span style=&#34;white-space: nowrap;&#34;>Some content from this outlet may be</span><br><span style=&#34;white-space: nowrap;&#34;>limited or behind a paywall.</span></p>"><i class="fa-regular fa-sack-dollar mr-1"></i><span class="whitespace-nowrap">Possible Paywall</span></div></div></div></div> </div> <p class="mt-2 mb-5 text-right"> <a id="More-headline-roundups" class="group relative pr-5 hover:no-underline border-b border-opacity-0 hover:border-opacity-100 border-color-text inline-block w-fit cursor-pointer text-sm no-underline" href="/headline-roundups">